Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Shelley Miyamoto

Concepts (390)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Heart Transplantation
39
2025
680
4.910
Why?
Heart Defects, Congenital
16
2025
910
2.870
Why?
Heart Failure
19
2025
2326
2.410
Why?
Cardiomyopathy, Dilated
14
2025
356
2.370
Why?
Heart Ventricles
15
2022
756
2.260
Why?
Myocytes, Cardiac
9
2026
546
1.910
Why?
MicroRNAs
9
2025
686
1.850
Why?
Heart-Lung Transplantation
2
2025
13
1.830
Why?
Circulating MicroRNA
3
2023
26
1.500
Why?
Cardiomyopathies
7
2023
335
1.470
Why?
Disease Management
4
2025
653
1.460
Why?
Lung Transplantation
2
2025
332
1.420
Why?
Myocardium
8
2021
935
1.360
Why?
Societies, Medical
2
2025
900
1.320
Why?
Hypoplastic Left Heart Syndrome
6
2017
119
1.280
Why?
Milrinone
2
2021
26
1.120
Why?
Phosphodiesterase 5 Inhibitors
2
2026
40
1.090
Why?
Ventricular Remodeling
4
2021
278
1.080
Why?
Mitochondria, Heart
3
2026
107
1.040
Why?
Child
66
2025
22739
1.030
Why?
Graft Rejection
9
2025
521
0.980
Why?
Cardiomyopathy, Hypertrophic
3
2023
143
0.900
Why?
Ventricular Function, Right
2
2018
297
0.890
Why?
Heart Diseases
5
2023
341
0.880
Why?
Ventricular Function, Left
6
2024
544
0.840
Why?
Graft Survival
8
2025
519
0.710
Why?
Cardiology
1
2025
362
0.700
Why?
Infant
33
2025
10090
0.650
Why?
Child, Preschool
40
2025
11868
0.640
Why?
Energy Metabolism
1
2026
935
0.630
Why?
Clinical Trials as Topic
1
2025
1062
0.620
Why?
Receptors, Adrenergic, beta
3
2016
58
0.610
Why?
Down-Regulation
4
2025
618
0.600
Why?
Mucocutaneous Lymph Node Syndrome
1
2020
94
0.590
Why?
Phosphodiesterase 3 Inhibitors
2
2016
14
0.580
Why?
Practice Guidelines as Topic
2
2025
1582
0.580
Why?
Cyclic Nucleotide Phosphodiesterases, Type 5
1
2018
23
0.560
Why?
Fever
1
2020
319
0.560
Why?
Humans
89
2026
145763
0.550
Why?
Pediatrics
2
2025
1125
0.510
Why?
Steroids
2
2015
160
0.510
Why?
Hypertrophy, Right Ventricular
1
2017
149
0.490
Why?
Hemodynamics
6
2015
1118
0.490
Why?
Male
60
2026
73003
0.480
Why?
Histone Deacetylases
1
2017
207
0.460
Why?
Fontan Procedure
4
2023
192
0.460
Why?
Female
64
2025
79035
0.450
Why?
Case-Control Studies
9
2025
3634
0.410
Why?
Echocardiography
6
2021
648
0.410
Why?
Immunosuppressive Agents
5
2025
838
0.390
Why?
Biomarkers
9
2021
4302
0.380
Why?
Adaptation, Physiological
2
2017
560
0.370
Why?
Receptors, Adrenergic, beta-2
1
2012
36
0.370
Why?
Adolescent
37
2025
22573
0.360
Why?
Waiting Lists
2
2013
266
0.360
Why?
Cardiovascular Diseases
2
2022
2191
0.350
Why?
Calcium-Binding Proteins
3
2021
221
0.340
Why?
Animals, Newborn
5
2021
896
0.340
Why?
Phosphoric Diester Hydrolases
3
2016
52
0.340
Why?
Adrenergic alpha-2 Receptor Agonists
3
2017
26
0.340
Why?
Recovery of Function
2
2015
716
0.330
Why?
Dexmedetomidine
3
2017
47
0.330
Why?
Gene Expression Regulation
3
2016
2601
0.330
Why?
Age Factors
10
2024
3346
0.320
Why?
Connexin 43
2
2025
36
0.310
Why?
Phenotype
4
2023
3170
0.310
Why?
Cells, Cultured
5
2026
4151
0.300
Why?
Primary Graft Dysfunction
1
2009
33
0.290
Why?
Cardiolipins
3
2021
82
0.290
Why?
Renal Insufficiency, Chronic
3
2025
668
0.290
Why?
Reoviridae Infections
1
2009
54
0.280
Why?
Rats, Sprague-Dawley
5
2021
2525
0.280
Why?
Granuloma, Plasma Cell
1
2008
12
0.280
Why?
Extracorporeal Membrane Oxygenation
2
2010
390
0.270
Why?
Adenosine Monophosphate
2
2021
85
0.270
Why?
Everolimus
2
2025
112
0.270
Why?
Myocarditis
1
2009
102
0.270
Why?
Prospective Studies
11
2021
8075
0.270
Why?
American Heart Association
3
2024
358
0.260
Why?
Mycophenolic Acid
2
2025
119
0.260
Why?
Retrospective Studies
23
2024
17325
0.260
Why?
Cardiac Catheterization
4
2017
559
0.260
Why?
Signal Transduction
3
2017
5223
0.250
Why?
Real-Time Polymerase Chain Reaction
3
2017
337
0.250
Why?
Tacrolimus
2
2025
196
0.250
Why?
Coronary Artery Disease
4
2024
750
0.250
Why?
Ventricular Outflow Obstruction
2
2022
38
0.250
Why?
Kidney Transplantation
2
2023
712
0.250
Why?
Phosphorylation
4
2021
1708
0.240
Why?
Treatment Outcome
16
2025
11793
0.230
Why?
Databases, Factual
5
2016
1491
0.230
Why?
Calcium
3
2021
1191
0.230
Why?
Adenylyl Cyclases
2
2016
60
0.220
Why?
Coronary Vessels
2
2017
246
0.210
Why?
Infant, Newborn
10
2021
6464
0.210
Why?
Fibrosis
2
2017
561
0.210
Why?
Heart-Assist Devices
4
2019
568
0.200
Why?
Glomerular Filtration Rate
2
2024
765
0.200
Why?
Cardiomyopathy, Restrictive
1
2023
11
0.200
Why?
Allografts
1
2024
152
0.190
Why?
Heart
3
2022
626
0.190
Why?
Pulmonary Artery
1
2009
1129
0.190
Why?
Sarcomeres
1
2023
97
0.190
Why?
Cyclic AMP
2
2014
208
0.180
Why?
Fibroma
1
2022
21
0.180
Why?
Data Accuracy
1
2022
65
0.180
Why?
Ventricular Dysfunction, Left
3
2024
394
0.180
Why?
Animals
12
2026
38097
0.180
Why?
Heart Neoplasms
1
2022
56
0.180
Why?
Barth Syndrome
1
2021
9
0.180
Why?
Electron Transport Complex I
1
2021
42
0.170
Why?
Focal Adhesions
1
2021
47
0.170
Why?
Transcriptome
2
2021
1042
0.170
Why?
RNA-Binding Proteins
1
2025
447
0.170
Why?
Longevity
1
2022
178
0.170
Why?
Fetofetal Transfusion
1
2021
26
0.170
Why?
Cytokines
1
2009
2069
0.170
Why?
Amniotic Fluid
1
2021
79
0.160
Why?
Cardiopulmonary Bypass
3
2022
219
0.160
Why?
Cardiac Output, Low
1
2021
53
0.160
Why?
Probenecid
1
2020
8
0.160
Why?
Calcium Channel Agonists
1
2020
12
0.160
Why?
Heart Rate
3
2023
856
0.160
Why?
Serum
2
2018
58
0.160
Why?
Metabolomics
1
2026
733
0.160
Why?
Cardiotonic Agents
1
2021
94
0.160
Why?
Predictive Value of Tests
2
2024
2123
0.160
Why?
Isoproterenol
2
2018
96
0.160
Why?
Apoptosis
1
2009
2443
0.160
Why?
Young Adult
13
2024
14251
0.160
Why?
Hypertension, Pulmonary
3
2017
1957
0.150
Why?
Immunoglobulins, Intravenous
1
2020
133
0.150
Why?
ROC Curve
3
2017
618
0.150
Why?
Time Factors
7
2024
7133
0.150
Why?
Atrial Function, Right
1
2019
14
0.150
Why?
Risk Factors
11
2024
10917
0.150
Why?
Sarcoplasmic Reticulum Calcium-Transporting ATPases
2
2021
32
0.150
Why?
Troponin I
1
2019
73
0.140
Why?
Phosphodiesterase Inhibitors
2
2016
73
0.140
Why?
Fatty Acids
1
2021
457
0.140
Why?
Tissue Donors
3
2016
420
0.140
Why?
Heart Atria
1
2019
141
0.140
Why?
Lymphoproliferative Disorders
2
2025
59
0.130
Why?
Surgical Wound Dehiscence
1
2017
22
0.130
Why?
Rats
5
2025
5585
0.130
Why?
Gene Regulatory Networks
1
2020
318
0.130
Why?
Kidney Failure, Chronic
1
2023
599
0.130
Why?
Protein Kinase C beta
1
2017
21
0.130
Why?
Receptors, Adrenergic, alpha-2
1
2017
11
0.130
Why?
Extracellular Matrix
1
2021
562
0.130
Why?
G-Protein-Coupled Receptor Kinase 2
1
2016
9
0.130
Why?
Tissue Inhibitor of Metalloproteinases
1
2016
16
0.130
Why?
Survival Analysis
4
2021
1378
0.120
Why?
Drug Administration Schedule
2
2017
782
0.120
Why?
Matrix Metalloproteinase 2
1
2016
56
0.120
Why?
Galectin 3
1
2016
21
0.120
Why?
Kaplan-Meier Estimate
3
2015
971
0.120
Why?
Genetic Markers
1
2017
338
0.120
Why?
Vectorcardiography
1
2016
4
0.120
Why?
Isoenzymes
1
2017
295
0.120
Why?
Electrocardiography
3
2015
668
0.120
Why?
Death, Sudden, Cardiac
1
2018
237
0.120
Why?
Research Design
1
2022
1139
0.120
Why?
Cytomegalovirus Infections
2
2025
206
0.120
Why?
Patient Transfer
1
2019
211
0.120
Why?
Self Care
1
2019
392
0.120
Why?
Gene Expression Regulation, Enzymologic
1
2017
267
0.120
Why?
Specimen Handling
1
2018
183
0.120
Why?
Plasma
1
2018
223
0.120
Why?
Vascular Resistance
1
2017
370
0.120
Why?
Sirolimus
1
2017
282
0.120
Why?
Adult
13
2024
40872
0.120
Why?
Statistics as Topic
1
2016
283
0.120
Why?
Transition to Adult Care
1
2017
103
0.120
Why?
Vasoconstriction
1
2017
216
0.120
Why?
Exosomes
1
2017
104
0.110
Why?
Mutation
3
2023
4090
0.110
Why?
Incidence
3
2025
2933
0.110
Why?
Arrhythmias, Cardiac
1
2018
356
0.110
Why?
Up-Regulation
1
2018
848
0.110
Why?
Vascular Endothelial Growth Factor A
1
2018
552
0.110
Why?
Perioperative Care
1
2017
231
0.110
Why?
Fibrin Fibrinogen Degradation Products
2
2012
92
0.110
Why?
Follow-Up Studies
7
2024
5428
0.110
Why?
DNA Copy Number Variations
1
2015
188
0.110
Why?
Diagnosis, Computer-Assisted
1
2015
92
0.110
Why?
Exercise Test
3
2023
630
0.110
Why?
Tachycardia, Ventricular
1
2016
180
0.100
Why?
Myocardial Contraction
3
2024
293
0.100
Why?
Surgical Wound Infection
1
2017
329
0.100
Why?
Hypoalbuminemia
1
2014
27
0.100
Why?
Ketamine
1
2015
137
0.100
Why?
Stroke Volume
2
2016
655
0.100
Why?
Gene Expression Profiling
2
2021
1777
0.100
Why?
Coronary Angiography
1
2016
328
0.100
Why?
Adrenergic beta-1 Receptor Antagonists
1
2013
9
0.100
Why?
Growth Disorders
1
2014
89
0.100
Why?
Anthracyclines
1
2013
49
0.100
Why?
Hypnotics and Sedatives
1
2015
222
0.100
Why?
Patient Compliance
1
2017
588
0.100
Why?
Prognosis
4
2015
4329
0.100
Why?
Vascular Diseases
1
2016
252
0.100
Why?
Organ Transplantation
1
2016
253
0.090
Why?
Fetal Heart
1
2013
56
0.090
Why?
Myosin Heavy Chains
1
2014
183
0.090
Why?
Propensity Score
1
2015
377
0.090
Why?
Interleukin-1
1
2016
961
0.090
Why?
Cerebral Arterial Diseases
1
2012
50
0.090
Why?
Patient Education as Topic
1
2017
777
0.090
Why?
Tissue and Organ Procurement
1
2016
343
0.090
Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
2012
165
0.090
Why?
Natriuretic Peptide, Brain
1
2012
109
0.090
Why?
Heart Arrest
1
2015
411
0.090
Why?
Calcium-Calmodulin-Dependent Protein Kinase Type 2
1
2014
196
0.090
Why?
Drug Therapy, Combination
2
2025
1043
0.080
Why?
Ventricular Dysfunction, Right
1
2014
248
0.080
Why?
Altitude
2
2021
463
0.080
Why?
Blood Coagulation Disorders
1
2012
198
0.080
Why?
Proto-Oncogene Proteins c-kit
1
2010
72
0.080
Why?
Postoperative Complications
5
2025
2977
0.080
Why?
Pulmonary Embolism
1
2012
241
0.080
Why?
Fibrinolytic Agents
1
2012
297
0.080
Why?
Mycoses
1
2010
88
0.080
Why?
RNA
1
2016
912
0.080
Why?
United States
8
2024
16123
0.080
Why?
Transplantation, Homologous
3
2021
419
0.070
Why?
Patient Selection
1
2014
739
0.070
Why?
Air Ambulances
1
2010
56
0.070
Why?
Transplantation Conditioning
1
2010
191
0.070
Why?
Thrombophilia
1
2009
89
0.070
Why?
Oxygen Consumption
2
2023
719
0.070
Why?
Transcription, Genetic
1
2015
1454
0.070
Why?
Colorado
6
2017
4556
0.070
Why?
Travel
1
2010
136
0.070
Why?
Mitral Valve Stenosis
1
2008
20
0.070
Why?
Health Knowledge, Attitudes, Practice
1
2017
1420
0.070
Why?
Cohort Studies
6
2015
6032
0.070
Why?
Angioplasty, Balloon
1
2009
94
0.070
Why?
RNA, Transfer, Glu
1
2007
6
0.070
Why?
Cardiac Surgical Procedures
2
2017
611
0.070
Why?
Cell Line
2
2025
2823
0.070
Why?
Registries
2
2014
2410
0.060
Why?
RNA, Messenger
3
2021
2805
0.060
Why?
Reoperation
3
2021
637
0.060
Why?
Multicenter Studies as Topic
2
2023
413
0.060
Why?
Mitochondrial Diseases
1
2007
92
0.060
Why?
Dose-Response Relationship, Drug
2
2025
2028
0.060
Why?
Oxidation-Reduction
2
2021
1068
0.060
Why?
Stem Cells
1
2010
630
0.060
Why?
Brain Ischemia
1
2009
359
0.060
Why?
Pregnancy
2
2021
7215
0.060
Why?
Stents
1
2009
564
0.050
Why?
3' Untranslated Regions
1
2025
149
0.050
Why?
Longitudinal Studies
2
2024
2967
0.050
Why?
Protein Isoforms
1
2025
399
0.050
Why?
Stroke
1
2012
1271
0.050
Why?
Echocardiography, Doppler
1
2024
115
0.050
Why?
Area Under Curve
1
2024
332
0.050
Why?
Polymerase Chain Reaction
2
2017
1043
0.050
Why?
Risk
2
2019
923
0.050
Why?
Blotting, Western
2
2016
1184
0.050
Why?
Pilot Projects
2
2019
1897
0.050
Why?
Oligonucleotide Array Sequence Analysis
2
2015
751
0.050
Why?
Severity of Illness Index
3
2021
2933
0.040
Why?
Endopeptidase K
1
2021
18
0.040
Why?
Ribonucleases
1
2021
48
0.040
Why?
Middle Aged
4
2016
36302
0.040
Why?
Light Coagulation
1
2021
10
0.040
Why?
Acyltransferases
1
2021
78
0.040
Why?
Systemic Inflammatory Response Syndrome
1
2022
95
0.040
Why?
Serum Response Factor
1
2021
33
0.040
Why?
Genotype
2
2017
1857
0.040
Why?
Fetoscopy
1
2021
33
0.040
Why?
Sensitivity and Specificity
2
2016
2000
0.040
Why?
Exercise Tolerance
1
2023
283
0.040
Why?
Microscopy, Atomic Force
1
2021
128
0.040
Why?
Gene Expression
2
2017
1478
0.040
Why?
Biomechanical Phenomena
1
2024
860
0.040
Why?
Palliative Care
1
2009
1022
0.040
Why?
Multivariate Analysis
2
2014
1547
0.040
Why?
TRPV Cation Channels
1
2020
43
0.040
Why?
Drainage
1
2021
185
0.040
Why?
Cluster Analysis
1
2021
501
0.040
Why?
Logistic Models
1
2024
2139
0.040
Why?
Resource Allocation
1
2019
52
0.040
Why?
Recurrence
2
2012
1139
0.040
Why?
Ultrasonography, Prenatal
1
2021
295
0.040
Why?
Ventricular Function
1
2019
53
0.040
Why?
Polymorphism, Single Nucleotide
2
2017
2181
0.040
Why?
Sequence Analysis, RNA
1
2021
442
0.040
Why?
HEK293 Cells
1
2021
741
0.040
Why?
Flecainide
1
2018
8
0.040
Why?
Treatment Failure
2
2010
360
0.030
Why?
DNA, Mitochondrial
1
2020
211
0.030
Why?
Intracellular Signaling Peptides and Proteins
1
2021
457
0.030
Why?
Exercise Therapy
1
2023
475
0.030
Why?
Risk Assessment
3
2016
3752
0.030
Why?
Guinea Pigs
1
2018
159
0.030
Why?
Inflammation
1
2009
2883
0.030
Why?
Chronic Disease
1
2024
1812
0.030
Why?
Ryanodine Receptor Calcium Release Channel
1
2018
72
0.030
Why?
Neoplasms
1
2013
2913
0.030
Why?
Administration, Oral
1
2020
867
0.030
Why?
Freezing
1
2018
83
0.030
Why?
Anti-Arrhythmia Agents
1
2018
144
0.030
Why?
Cell Differentiation
1
2025
2050
0.030
Why?
Atrial Natriuretic Factor
1
2016
55
0.030
Why?
Adenoidectomy
1
2017
81
0.030
Why?
Cell Size
1
2017
93
0.030
Why?
Sampling Studies
1
2016
98
0.030
Why?
Observer Variation
1
2017
357
0.030
Why?
Renin-Angiotensin System
1
2017
80
0.030
Why?
Homeostasis
1
2020
644
0.030
Why?
Randomized Controlled Trials as Topic
1
2023
1751
0.030
Why?
Brain Death
1
2016
60
0.030
Why?
Sympathetic Nervous System
1
2017
181
0.030
Why?
Autopsy
1
2016
94
0.030
Why?
Kidney
1
2023
1496
0.030
Why?
Tonsillectomy
1
2017
105
0.030
Why?
Stem Cell Transplantation
1
2017
189
0.030
Why?
Diastole
1
2016
146
0.030
Why?
Systole
1
2016
181
0.030
Why?
Carrier Proteins
1
2019
729
0.030
Why?
Italy
1
2015
117
0.030
Why?
Disease Models, Animal
2
2018
4568
0.030
Why?
Markov Chains
1
2015
132
0.030
Why?
DNA, Complementary
1
2015
273
0.030
Why?
Cardiac Output
1
2015
179
0.030
Why?
Reference Values
1
2016
798
0.030
Why?
Orthopedic Procedures
1
2017
244
0.030
Why?
Action Potentials
1
2018
502
0.030
Why?
Mitochondria
1
2021
992
0.030
Why?
Hot Temperature
1
2018
396
0.030
Why?
Arterial Pressure
1
2015
134
0.030
Why?
Feasibility Studies
1
2019
1115
0.030
Why?
Self-Management
1
2017
204
0.030
Why?
Public Health
1
2019
574
0.030
Why?
Exons
1
2015
364
0.030
Why?
Cardiovascular Surgical Procedures
1
2014
30
0.030
Why?
Linear Models
1
2016
849
0.030
Why?
Analysis of Variance
1
2016
1300
0.030
Why?
Induced Pluripotent Stem Cells
1
2017
273
0.020
Why?
Drug Therapy
1
2014
84
0.020
Why?
Analgesics
1
2015
231
0.020
Why?
Odds Ratio
1
2016
1083
0.020
Why?
Pandemics
1
2022
1711
0.020
Why?
Program Evaluation
1
2017
944
0.020
Why?
Self Report
1
2017
876
0.020
Why?
Antibiotics, Antineoplastic
1
2013
140
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2014
849
0.020
Why?
Transplant Recipients
1
2014
182
0.020
Why?
Mitochondrial Proteins
1
2014
263
0.020
Why?
Heart Function Tests
1
2012
59
0.020
Why?
Diagnosis, Differential
1
2016
1512
0.020
Why?
Mice
3
2015
18355
0.020
Why?
Nutritional Status
1
2014
353
0.020
Why?
Exercise
1
2023
2205
0.020
Why?
Mice, Inbred C3H
1
2010
254
0.020
Why?
Proportional Hazards Models
1
2014
1330
0.020
Why?
France
1
2010
40
0.020
Why?
Diagnostic Imaging
1
2012
337
0.020
Why?
Body Weight
1
2014
972
0.020
Why?
Shock, Cardiogenic
1
2010
65
0.020
Why?
Chi-Square Distribution
1
2010
528
0.020
Why?
Adaptive Immunity
1
2010
167
0.020
Why?
Bone Marrow Transplantation
1
2010
298
0.020
Why?
Bone Marrow Cells
1
2010
322
0.020
Why?
Internationality
1
2010
156
0.020
Why?
Factor VIII
1
2009
106
0.020
Why?
Tricuspid Atresia
1
2008
4
0.020
Why?
Venae Cavae
1
2008
7
0.020
Why?
Survival Rate
1
2014
2094
0.020
Why?
Mass Screening
1
2017
1361
0.020
Why?
Vena Cava, Superior
1
2008
25
0.020
Why?
Biopsy
1
2012
1082
0.020
Why?
Device Removal
1
2009
142
0.020
Why?
Age of Onset
1
2009
557
0.020
Why?
Anastomosis, Surgical
1
2008
162
0.020
Why?
Mice, Inbred BALB C
1
2010
1261
0.020
Why?
Probability
1
2008
308
0.020
Why?
C-Reactive Protein
1
2009
423
0.020
Why?
Reproducibility of Results
1
2015
3416
0.020
Why?
Anticoagulants
1
2012
748
0.020
Why?
Fatal Outcome
1
2007
305
0.020
Why?
Pulmonary Circulation
1
2008
430
0.010
Why?
Combined Modality Therapy
1
2008
1270
0.010
Why?
Surveys and Questionnaires
1
2017
6085
0.010
Why?
Aged
2
2014
26215
0.010
Why?
Length of Stay
1
2008
1350
0.010
Why?
T-Lymphocytes
1
2010
1997
0.010
Why?
Miyamoto's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)